Commercializing Cell and Gene Therapies
COMMERCIALIZING CELL AND GENE THERAPIES
It takes a commitment to innovation, seamless coordination and the support of an experienced partner to overcome every barrier on the journey from clinical to commercial success.
Every moment counts when working with life-saving and industry changing treatments. Our white paper offers actionable insights for those ready to shape this new landscape. Authored by AmerisourceBergen’s multi disciplinary and market-leading experts, readers will learn what it takes to design an effective commercialization strategy and execute an integrated solution when the patient is in the supply chain.
Download our white paper for key takeaways related to:
- cGMP manufacturing
- Securing regulatory approval
- Integrating supply chain and logistics strategy
- Critical success factors for market access
- Creating a differentiated patient and provider experience
- Managing payment and distribution
As cell and gene therapies move through clinical trials and advance toward a commercial launch, innovators must overcome unprecedented challenges. In many cases, this will require redefining established approaches within many areas of commercialization. Success will require partnership. We’re here to ensure you achieve it.